TTKHLTCARE1,138.80

TTK Healthcare Limited

· Others
₹ CrorePeersDCMSHRIRAMBALMLAWRIEGODREJIND3MINDIAMcap ₹1,609 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth+6.5+7.0
EBITDA Growth-6.7-24.8
EBIT Growth+9.2-34.3
Net Income Growth+29.9-19.6
EPS Growth+30.0-19.6
Total Assets Growth+6.7+3.7
Total Equity Growth+6.4+4.7
Cash from Operations Growth+19.6-431.9
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.